Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 May;403(3):289-307.
doi: 10.1007/s00423-018-1649-2. Epub 2018 Jan 19.

Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience

Affiliations
Review

Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience

F Rassam et al. Langenbecks Arch Surg. 2018 May.

Abstract

Aim: Perihilar cholangiocarcinoma (PHC) is a challenging disease and requires aggressive surgical treatment in order to achieve curation. The assessment and work-up of patients with presumed PHC is multidisciplinary, complex and requires extensive experience. The aim of this paper is to review current aspects of diagnosis, preoperative work-up and extended resection in patients with PHC from the perspective of our own institutional experience with this complex tumor.

Methods: We provided a review of applied modalities in the diagnosis and work-up of PHC according to current literature. All patients with presumed PHC in our center between 2000 and 2016 were identified and described. The types of resection, surgical techniques and outcomes were analyzed.

Results and conclusion: Upcoming diagnostic modalities such as Spyglass and combinations of serum biomarkers and molecular markers have potential to decrease the rate of misdiagnosis of benign, inflammatory disease. Assessment of liver function with hepatobiliary scintigraphy provides better information on the future remnant liver (FRL) than volume alone. The selective use of staging laparoscopy is advisable to avoid futile laparotomies. In patients requiring extended resection, selective preoperative biliary drainage is mandatory in cholangitis and when FRL is small (< 50%). Preoperative portal vein embolization (PVE) is used when FRL volume is less than 40% and optionally includes the left portal vein branches to segment 4. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) as alternative to PVE is not recommended in PHC. N2 positive lymph nodes preclude long-term survival. The benefit of unconditional en bloc resection of the portal vein bifurcation is uncertain. Along these lines, an aggressive surgical approach encompassing extended liver resection including segment 1, regional lymphadenectomy and conditional portal venous resection translates into favorable long-term survival.

Keywords: Biliary drainage; Biomarkers; Diagnosis; Hepato-biliary scintigraphy; Klatskin tumor; Perihilar cholangiocarcinoma; Postoperative outcome; Preoperative assessment; Staging; Surgical resection.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Figures

Fig. 1
Fig. 1
Bismuth-Corlette classification for staging of perihilar cholangiocarcinoma
Fig. 2
Fig. 2
Flow diagram of patients referred to the AMC with suspicion on PHC (2000–2016)
Fig. 3
Fig. 3
Overall survival in 170 patients undergoing resection of pathology proven PHC in the AMC. The 5-year survival rate after resection was 44.3%
Fig. 4
Fig. 4
Flowchart showing work-up and treatment of patients suspected of PHC
Fig. 5
Fig. 5
Extended resection for PHC should include the central sector (segment 4) with segment 1 along the antero-posterior axis of the liver. Depending on the predominant side of the tumor, a left (extended) or right extended hemihepatectomy is chosen for en bloc resection of the hilar area

References

    1. Aljiffry M, Abdulelah A, Walsh M, et al. Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature. J Am Coll Surg. 2009;208:134–147. doi: 10.1016/j.jamcollsurg.2008.09.007. - DOI - PubMed
    1. Gatto M, Alvaro D. New insights on cholangiocarcinoma. World J Gastrointest Oncol. 2010;2:136–145. doi: 10.4251/wjgo.v2.i3.136. - DOI - PMC - PubMed
    1. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet (London, England) 2005;366:1303–1314. doi: 10.1016/S0140-6736(05)67530-7. - DOI - PubMed
    1. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg. 1992;215(1):31–38. doi: 10.1097/00000658-199201000-00005. - DOI - PMC - PubMed
    1. Vaeteewoottacharn K, Seubwai W, Bhudhisawasdi V, et al. Potential targeted therapy for liver fluke associated cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2014;21:362–370. doi: 10.1002/jhbp.65. - DOI - PubMed

MeSH terms